Concepedia

Gholamhossein Amini Chermahini

GA

Statistics

Publications

5

Citations

231

H-Index

5

Active since

2015

Affiliations

The Ohio State University(Current)

Nationwide Children's Hospital

Ege University

University of Massachusetts Chan Medical School

Gholamhossein Amini Chermahini is an author at The Ohio State University specializing in gene expression, gene therapy, and muscular dystrophy.

Publications per year

2015–2021

5

Publications

5

AAV-mediated follistatin gene therapy improves functional outcomes in the TIC-DUX4 mouse model of FSHD

Carlee R. Giesige, Lindsay M. Wallace, Kristin N. Heller et al. · JCI Insight · 2018 · 74 citations · Full text

, , +14

Fetal Gene Therapy Using a Single Injection of Recombinant AAV9 Rescued SMA Phenotype in Mice

Afrooz Rashnonejad, Gholamhossein Amini Chermahini, Cumhur Gündüz et al. · Molecular Therapy · 2019 · 58 citations · Full text

, , +17

Human miRNA miR-675 inhibits DUX4 expression and may be exploited as a potential treatment for Facioscapulohumeral muscular dystrophy

Nizar Y. Saad, Mustafa Al-Kharsan, Sara E. Garwick-Coppens et al. · Nature Communications · 2021 · 56 citations · Full text

, , +17

Large-Scale Production of Adeno-Associated Viral Vector Serotype-9 Carrying the Human Survival Motor Neuron Gene

Afrooz Rashnonejad, Gholamhossein Amini Chermahini, Shaoyong Li et al. · Molecular Biotechnology · 2015 · 26 citations

, , +16

RNAscope in situ hybridization-based method for detecting <i>DUX4</i> RNA expression in vitro

Gholamhossein Amini Chermahini, Afrooz Rashnonejad, Scott Q. Harper · RNA · 2019 · 17 citations · Full text

, , +12

1–5 of 5